ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,646,000 | +54.5% | 642,226 | -4.0% | 0.11% | +45.3% |
Q2 2020 | $1,713,000 | -6.1% | 669,042 | +6.0% | 0.08% | -29.2% |
Q1 2020 | $1,825,000 | -23.4% | 631,447 | +0.4% | 0.11% | +5.0% |
Q4 2019 | $2,384,000 | -27.1% | 629,124 | -1.6% | 0.10% | -34.0% |
Q3 2019 | $3,269,000 | -24.7% | 639,094 | -8.7% | 0.15% | -12.1% |
Q2 2019 | $4,341,000 | -2.5% | 700,176 | +11.8% | 0.17% | -3.9% |
Q1 2019 | $4,453,000 | -19.8% | 626,247 | -3.7% | 0.18% | -33.7% |
Q4 2018 | $5,554,000 | -58.1% | 650,349 | -1.8% | 0.27% | -43.9% |
Q3 2018 | $13,264,000 | -19.8% | 662,544 | +3.5% | 0.49% | -22.0% |
Q2 2018 | $16,529,000 | +10.5% | 639,934 | +2.2% | 0.62% | +4.0% |
Q1 2018 | $14,964,000 | -18.7% | 626,113 | +15.3% | 0.60% | -15.4% |
Q4 2017 | $18,399,000 | +64.6% | 542,897 | +2.8% | 0.71% | +55.8% |
Q3 2017 | $11,179,000 | +20.0% | 528,067 | -0.9% | 0.46% | +17.0% |
Q2 2017 | $9,317,000 | +2.6% | 532,727 | +2.7% | 0.39% | +4.3% |
Q1 2017 | $9,077,000 | +3.6% | 518,685 | +0.0% | 0.37% | -0.3% |
Q4 2016 | $8,763,000 | +5.9% | 518,545 | +2.8% | 0.37% | +1.6% |
Q3 2016 | $8,278,000 | +7.2% | 504,474 | -1.1% | 0.37% | -1.1% |
Q2 2016 | $7,724,000 | +4.7% | 510,194 | 0.0% | 0.37% | +3.6% |
Q1 2016 | $7,377,000 | -43.6% | 510,194 | +10.4% | 0.36% | -41.9% |
Q4 2015 | $13,085,000 | +122.4% | 462,051 | +31.4% | 0.62% | +101.3% |
Q3 2015 | $5,884,000 | -35.6% | 351,521 | +0.8% | 0.31% | -29.6% |
Q2 2015 | $9,143,000 | +61.8% | 348,721 | +8.1% | 0.44% | +53.5% |
Q1 2015 | $5,652,000 | +35.5% | 322,631 | +34.3% | 0.28% | +28.5% |
Q4 2014 | $4,172,000 | +39.6% | 240,167 | +49.7% | 0.22% | +24.9% |
Q3 2014 | $2,988,000 | +7.8% | 160,463 | +5.8% | 0.18% | +13.5% |
Q2 2014 | $2,772,000 | – | 151,619 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |